Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial

Published: 25-09-2020| Version 1 | DOI: 10.17632/6k45whwfcp.1
Contributors:
Amy S. Paller,
Brad Shumel

Description

Author video for the article: Paller AS, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020 Jun 20;S0190-9622(20)31152-X. doi: 10.1016/j.jaad.2020.06.054

Files